Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Passage Bio Inc (NQ: PASG ) 0.7130 +0.0330 (+4.85%) Streaming Delayed Price Updated: 1:41 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Passage Bio Inc < Previous 1 2 3 4 5 Next > Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday November 14, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Via Benzinga Recap: Passage Bio Q3 Earnings November 13, 2023 Via Benzinga Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights November 13, 2023 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session November 03, 2023 Via Benzinga Recap: Passage Bio Q1 Earnings May 11, 2023 Via Benzinga Passage Bio's Earnings: A Preview March 03, 2023 Via Benzinga Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference October 30, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 20, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference September 25, 2023 From Passage Bio Via GlobeNewswire Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights August 07, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study August 07, 2023 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session August 03, 2023 Via Benzinga Passage Bio to Participate in Upcoming Investor Conferences August 01, 2023 From Passage Bio Via GlobeNewswire Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors July 31, 2023 From Passage Bio Via GlobeNewswire Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying June 30, 2023 The Dow Jones closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Stocks That Hit 52-Week Lows On Thursday June 15, 2023 On Thursday, 64 companies achieved new lows for the year. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday June 14, 2023 On Wednesday, 33 stocks hit new 52-week lows. Via Benzinga Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference June 05, 2023 From Passage Bio Via GlobeNewswire Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights May 11, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 21, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit April 17, 2023 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session April 03, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Monday March 27, 2023 On Monday, 89 stocks made new 52-week lows. Via Benzinga Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days March 27, 2023 From Passage Bio Via GlobeNewswire Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights March 06, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Cowen 43rd Annual Health Care Conference February 28, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023 February 27, 2023 From Passage Bio Via GlobeNewswire Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023 February 24, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023 February 15, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) January 20, 2023 From Passage Bio Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.